OncXerna Therapeutics Company

OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.
Industry: Clinical Development, Gene therapy, Preclinical Development
Headquarters: Waltham, Massachusetts, United States
Founded Date: 2018-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 6
Total Funding: 126500000
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-03-03
Last Funding Type: Venture - Series Unknown

Visit Website
https://twitter.com/OncXerna
Register and Claim Ownership